Logo image
Dr. Karina Knorr working place, University Hospital Rechts der Isar Munich
Dr. Karina Knorr
Excellent
AiroScore
9.90

Dr. Karina Knorr

nuclear medicine, theranostics
nuclear medicine, theranostics
User ScoreExperienceRatingPrice RangePublicationsOnline Consultations
98%8 years9.9/10$$$$229No

Overview

Country, City
Germany, Munich
Health facility
University Hospital Rechts der Isar Munich
Medical unit
Department of nuclear medicine, molecular and radionuclide therapy

About the doctor

Dr. Karina Knorr, a nuclear medicine specialist with many years of experience, currently serves as the Deputy Head of the Theranostics Section at Rechts der Isar Hospital. Her impressive career features include publications focusing on PSMA-targeted radioligand therapy in prostate cancer and research on PET-CT and PET-MRI imaging. Dr. Knorr's expertise lies in predictive factors for radioligand therapy, with a particular emphasis on treatment outcomes and patient safety in metastatic castration-resistant prostate cancer. With a background in nuclear medicine and a wealth of scientific publications, Dr. Knorr's work showcases her dedication to advancing treatment options for prostate cancer patients. Her research not only delves into novel biomarkers for prognosis but also explores the efficacy of various radioligand therapies. Dr. Karina Knorr's commitment to improving patient outcomes and safety in the field of nuclear medicine makes her a standout physician at Rechts der Isar Hospital.

Resume

CV (Curriculum Vitae)

Experience
  • 2018-2021 Specialist in nuclear medicine, Ulm Radiology Center
  • 2021 Senior physician, the Rechts der Isar Hospital
  • 2021 Deputy Head of the Theranostics Section, the Rechts der Isar Hospital

Languages

English flag
English
German flag
German

Publications

Assessment of nephrotoxicity following lutetium-177 PSMA I&T radioligand therapy: a comparative study with docetaxel chemotherapy

16 April, 2026

Fully automated spleen segmentation predicts progression-free survival in HCC patients following transarterial radioembolization

17 February, 2026

Fully automated spleen segmentation predicts progression-free survival in HCC patients following transarterial radioembolization.

17 February, 2026

Location

Hörsaal A, Klinikum rechts der Isar, Ismaninger Str. 22, 81675 München, Germany

FAQ

Where does the doctor practice?

What is the specialization of Dr. Karina Knorr?

The primary specialization of the doctor is nuclear medicine, theranostics.

What is the experience of the specialist?

Dr. Karina Knorr has been practicing for more than 8 years.

What is the rating of the doctor?

Dr. Karina Knorr is rated as 9.90 by AiroMedical.

Is the specialist involved in the research?

Does the specialist offer online consultations?

No, Dr. Karina Knorr doesn’t perform virtual appointments.

Dr. Karina Knorr
Dr. Karina Knorr

Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

© Dr. Karina Knorr